Olon SpA
Rodano, Milan, Italy
Program data pending ClinicalTrials.gov matching
—
Not Assessed
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, HPAPI, ADC Payload/Linker Synthesis, ADC Bioconjugation, Fill-Finish, Biologics (Mammalian)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press8 articles
Broad modality coverage (6 modalities)
Recent News 8 articles
Olon S.p.A. Expands Microbial GMP Capabilities at Its Manufacturing Site in Capua - BioSpace
Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing - PR Newswire
Olon Buys Indian API Plant - CHEManager
Olon SpA Acquires Italian CDMO - Contract Pharma
Olon SpA - Via Ritzau
Olon acquires fellow Italian CDMO - The Pharma Letter
Olon S.p.A. Acquires Capua BioServices S.p.A. - PR Newswire
Olon S.p.A. (P&R Group) Acquires Ricerca Biosciences’ Chemical Division In Ohio (USA) - BioSpace
Represent this organization? Contact us to verify or update this profile.